(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-26 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 1434360
| Date | Daily Closing Price | Open | High | Low | Volume |
| 26 Tue Mar 2024 | 1.52 | 1.45 | 1.57 | 1.38 | 0.833 times |
| 25 Mon Mar 2024 | 1.44 | 1.46 | 1.56 | 1.42 | 0.82 times |
| 22 Fri Mar 2024 | 1.44 | 1.34 | 1.49 | 1.32 | 1.166 times |
| 21 Thu Mar 2024 | 1.34 | 1.29 | 1.40 | 1.29 | 0.801 times |
| 20 Wed Mar 2024 | 1.33 | 1.44 | 1.44 | 1.24 | 2.147 times |
| 19 Tue Mar 2024 | 1.41 | 1.45 | 1.52 | 1.38 | 0.822 times |
| 18 Mon Mar 2024 | 1.47 | 1.50 | 1.51 | 1.36 | 0.762 times |
| 15 Fri Mar 2024 | 1.48 | 1.47 | 1.49 | 1.42 | 0.442 times |
| 14 Thu Mar 2024 | 1.46 | 1.55 | 1.56 | 1.41 | 0.934 times |
| 13 Wed Mar 2024 | 1.59 | 1.56 | 1.70 | 1.47 | 0.975 times |
Share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Target | 0.42 |
| Downside Target | 0.43 |
| Downside Target | 0.60 |
| Downside Target | 0.65 |
| Downside Target | 0.84 |
| Downside Target | 0.92 |
| Downside Target | 1.04 |
| Downside Target | 1.24 |
| Downside Target | 1.38 |
| Downside Target | 1.41 |
| Downside Target | 1.52 |
| Upside Target | 1.57 |
| Upside Target | 1.79 |
| Upside Target | 1.80 |
| Upside Target | 2.05 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Intraday Target | 1.41 |
| Downside Intraday Target | 1.3 |
| Upside Intraday Target | 1.6 |
| Upside Intraday Target | 1.68 |
| Downside Intraday Target | 1.49 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 26 Tue Mar 2024 | 1.52 | 1.46 | 1.57 | 1.38 | 0.29 times |
| 22 Fri Mar 2024 | 1.44 | 1.50 | 1.52 | 1.24 | 1.152 times |
| 15 Fri Mar 2024 | 1.48 | 1.80 | 1.80 | 1.41 | 0.379 times |
| 08 Fri Mar 2024 | 1.75 | 1.63 | 2.05 | 1.38 | 2.314 times |
| 01 Fri Mar 2024 | 1.59 | 1.50 | 1.79 | 1.43 | 1.204 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 26 Tue Mar 2024 | 1.52 | 1.56 | 2.05 | 1.24 | 0.994 times |
| 29 Thu Feb 2024 | 1.57 | 1.03 | 1.79 | 0.92 | 0.965 times |
| 31 Wed Jan 2024 | 0.96 | 0.81 | 1.04 | 0.65 | 2.174 times |
| 29 Fri Dec 2023 | 0.79 | 0.47 | 0.84 | 0.43 | 2.077 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term but the sell signal is initial and weak.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.43 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term but the sell signal is initial and weak.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.43 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.